-transparent.png){kind=logo}
Serum gastrin concentrations were measured in insulin-dependent diabetics and in patients who had undergone total duodenopancreatectomy and gastrectomy. Administration of somatostatin markedly inhibited gastrin release in the diabetic patients with an intact gastrointestinal tract. This inhibitory effect of somatostatin, however, is not detectable in the group of operated patients, who display basically low plasma gastrin levels. A marked increase in the plasma gastrin level after withdrawal of somatostatin was observed in patients with a normal gastrointestinal tract. This rebound effect was only slight in the operated patients.
Related Publications
H Pointner, and
U Flegel, and
K H Tragl, and
G Hengl
January 1979,
MMW, Munchener medizinische Wochenschrift,
H Pointner, and
U Flegel, and
K H Tragl, and
G Hengl
September 1974,
Deutsche medizinische Wochenschrift (1946),
H Pointner, and
U Flegel, and
K H Tragl, and
G Hengl
January 1982,
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
H Pointner, and
U Flegel, and
K H Tragl, and
G Hengl
July 1978,
Medizinische Klinik,
H Pointner, and
U Flegel, and
K H Tragl, and
G Hengl
June 1977,
Klinische Wochenschrift,
H Pointner, and
U Flegel, and
K H Tragl, and
G Hengl
May 1974,
Klinische Wochenschrift,
H Pointner, and
U Flegel, and
K H Tragl, and
G Hengl
December 1981,
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
H Pointner, and
U Flegel, and
K H Tragl, and
G Hengl
June 1977,
Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie,
H Pointner, and
U Flegel, and
K H Tragl, and
G Hengl
June 1974,
Nihon eiseigaku zasshi. Japanese journal of hygiene,
H Pointner, and
U Flegel, and
K H Tragl, and
G Hengl
April 1978,
Revista medica de Chile,
